The repair of critical-sized defects (CSDs) is a significant challenge in bone tissue engineering. Combining the use of progenitor cells with gene therapy represents a promising approach for bone regeneration. MicroRNAs play important roles in most gene regulatory networks, regulate the endogenous expression of multiple growth factors and simultaneously modulate stem cell differentiation. Our previous study showed that knocking down miR-31 promotes the osteogenesis of bone marrow stromal stem cells (BMSCs). To investigate the therapeutic potential of cells engineered to express anti-miR-31 for CSD repair, lentiviral vectors encoding negative control, miR-31 precursor and anti-sense sequences were constructed and transduced into osteo-inductive BMSCs. The expression of osteogenic-specific genes, alkaline phosphatase activity and Alizarin Red S staining were investigated to evaluate the effects of miR-31 on the cell fate of BMSCs over a 3-week period. In addition, miR-31-modified BMSCs seeded on poly(glycerol sebacate) (PGS) scaffolds were used to repair 8 mm critical-sized calvarial defects in rats. The results showed that miR-31 suppression significantly increased the expression of osteogenic-specific genes in vitro at the mRNA and protein levels, and that robust new bone formation with high local bone mineral density was observed in the anti-miR groups in vivo. Moreover, the PGS scaffolds carrying anti-miR-31-expressing BMSCs exhibited good biocompatibility and a high regeneration rate (~60 %) within in vivo bone defects. Our results suggest that miR-31 gene delivery affects the potential of BMSCs for osteogenic differentiation and bone regeneration and that PGS is a potential substrate for genetically modified, tissue-engineered bone in the repair of large bone defects.
Introduction
A critical-sized defect (CSD) is a defect that does not heal spontaneously during the lifetime of the animal (Schmitz and Hollinger, 1986) . Strategies to repair bone defects generally focus on preserving equivalent tissue engineering standards to heal CSDs caused by trauma or disease (Al Ruhaimi, 2001; Handa et al., 2012) . Osteoconductive and osteo-inductive autografts are the gold standard for the clinical repair of bone defects. However, they have several disadvantages, including infection, pain, loss of function, restricted supply due to the shortage of donors and morbidity . The use of tissue-engineered bone grafts, which are commonly used for materials and gene therapy, has become a promising therapeutic approach for bone regeneration (Lin et al., 2012; Fu et al., 2013; Liu et al., 2013) . Growth factors that stimulate stem cell osteogenesis and angiogenesis play an important role in repairing bone defects with tissueengineered bone. Many factors, such as bone morphogenic proteins (BMPs), vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α), stimulate osteogenesis and angiogenesis in genetically modified, tissue-engineered bone that is placed in bone defects Zou et al., 2012; Ding et al., 2013; Kim et al., 2013; Xiao et al., 2013) .
MicroRNAs (miRNAs) are small single-stranded RNA molecules (approximately 22 nucleotides in length) that do not encode protein. Instead, they regulate the expression of proteins by decreasing the level of target messenger RNA (mRNA) or binding to the 3' UTR of target mRNA and inhibiting mRNA translation (Hobert, 2008) . Consequently, miRNAs have become important tools in biological and medical research and are increasingly applied to treat and monitor disease. Overexpression or inhibition of miRNAs can simultaneously modulate the endogenous expression of multiple growth factors (Yau et al., 2012) . Therefore, delivery of select miRNAs might optimise bone regeneration by coordinating endogenous angiogenesis and osteogenesis . In addition, studies have shown that using miRNA to modify mesenchymal stem cells (MSCs) as seed cells is a promising approach for tissue regeneration Suh et al., 2013) .
Bone mesenchymal stem cells (BMSCs) have the potential to undergo multilineage differentiation into multiple tissue cell types, such as osteoblasts, chondrocytes 
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and adipocytes (Pittenger et al., 1999) . is involved in regulating tumour cell motility and targets special AT-rich sequence-binding protein 2 (Satb2) in cancer-associated fibroblasts (Aprelikova et al., 2010) . Satb2 is a pivotal regulator of multiple osteogenicspecific genes involved in osteoblastic differentiation and bone development (Dobreva et al., 2006) . We previously demonstrated that the expression of miR-31 is suppressed in osteo-inductive BMSCs and that knocking down endogenous miR-31 dramatically improves the osteogenic potential of BMSCs (Deng et al., 2013a) . In the present study, we explored whether miR-31 regulates Satb2 during the differentiation of BMSCs over a prolonged period.
We also investigated whether miR-31-modified BMSCs enhance in vivo bone regeneration in CSD repair. Polymeric biomaterials play an important role in bone tissue engineering (Rezwan et al., 2006) . Ideally, the polymers used in bone tissue engineering should have good biocompatibility, controlled biodegradability, excellent mechanical strength and defined bioactivity (You et al., 2012) . Poly(glycerol sebacate) (PGS) is an inexpensive, non-cytotoxic biodegradable polymer (Wang et al., 2002; Chen et al., 2013) that has been investigated for tissue engineering of retinal, neuronal, myocardial and vascular systems (Sundback et al., 2005; Pritchard et al., 2010; Kharaziha et al., 2013; . PGS and modified PGS polymers have also been explored for bone tissue engineering. Examples include a PGS-bioglass composite for the repair of injured bone (Chen et al., 2010) and a PGS/hydroxyapatite composite for bone regeneration (Bodakhe et al., 2013) .
In our recently published data (Zaky et al., 2014) , a critical size defect in ulna of rabbit was healed by employing the elastomeric polymer, the results show that PGS elastomer is an auspicious osteoconductive material for the regeneration of bony defects. Also, our studies Lee et al., 2013) showed that PGS induces angiogenic differentiation of bone marrow mononuclear cells and performed well in vascular tissue engineering. Furthermore, the process of angiogenesis usually coupled with osteogenesis in tissue engineering strategies (Kanczler and Oreffo, 2008; Nguyen et al., 2012) . Compared to a ceramic material such as β-tricalcium phosphate (β-TCP) with good osteo-inductive capacity (Yuan et al., 2007) , PGS promotes bone regeneration coupling with angiogenesis. As stated above, PGS scaffold is a hopeful candidate for tissue engineering of bone. In the present study, we used PGS as a scaffold to provide the ingrowth space and microenvironment for transplanted cells.
We combined porous PGS scaffolds and BMSCs that were modified by miR-31 or by anti-sense treatment to repair large bone defects. Here, we describe how BMSCs modified by miR-31 gene therapy and grown on a PGS scaffold can be used to promote the repair of large CSDs in a rat skull model.
Materials and Methods

Cell culture
Bone marrow was harvested from the femora and tibiae of 4-week-old male Fischer 344 rats according to a reported protocol (Soleimani and Nadri, 2009 ). The isolated BMSCs were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY, USA) containing 10 % foetal bovine serum (FBS) (Gibco) and 100 units/mL penicillin at 37 °C in an atmosphere of 5 % CO 2 . BMSCs were subcultured using 0.25 % trypsin containing 0.02 % EDTA. For osteo-inductive differentiation, the culture medium was supplemented with 10 -8 M dexamethasone, 10 mM β-glycerol phosphate and 50 mg/mL of L-ascorbic acid (Sigma, St. Louis, MO, USA). Flow cytometry was used to characterise the BMSCs according to their CD31, CD34, CD90 and CD105 staining (BD Biosciences) as previously described (Zou et al., 2011a) .
Lentiviral vector construction and gene transduction
For miR-31 overexpression, the precursor sequence for miR-31 was amplified from the genomic Rattus DNA by polymerase chain reaction (PCR) including overhang sequences from a 5' BamH1 and a 3' EcoR1-restriction site and cloned into hU6-MCS-PGK-EGFP lentiviral vectors (Hanbio, Shanghai, China). For miR-31 inhibition, self-complementary DNA oligonucleotides (anti-miR) encompassing the sequence Rattus miR-31 and irrelevant sequence (negative control, miR-Neg) were chemically synthesised including the same restriction sites as miR-31 precursor. The sense and anti-sense oligomers were annealed then inserted into hU6-MCS-PGK-EGFP lentiviral vectors as well. Both of the recombinant lentiviruses were produced by co-transfection of 293T cells with plasmids PSPAX2 and PMD2G using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Lentivirus-containing supernatants were harvested 48 h after transfection and filtered through 0.22 μm cellulose acetate filters (Millipore, Billerica, MA, USA). Recombinant lentiviruses were concentrated by ultracentrifugation (2 h at 50,000 g). For transduction, lentiviral vectors encoding miR-31, anti-miR and miR-Neg were added to reach an MOI of 50, BMSCs were incubated with the lentiviruses and 8 μg/mL polybrene for 24 h. The transduction efficiency of the lentiviruses was calculated from the proportion of GFP-positive BMSCs determined using flow cytometry. The miR-31 expression levels in the gene-modified cells at various time points were determined using qPCR analysis.
Quantitative real-time RT-PCR analysis (qPCR)
The total RNA was extracted from the transfected BMSCs using TRIzol reagent (Invitrogen), and cDNA was synthesised using the PrimeScript RT reagent kit (TaKaRa, Dalian, China). The qPCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and a 7500 Real-Time PCR Detection System. The sequences of the primers for the osteogenic marker genes, including runt-related transcription factor 2 (Runx2), special AT-rich sequence binding protein 2 (Satb2), osteopontin (Opn) and osteocalcin (Ocn), as well Y Deng et al.
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as GAPDH, were previously reported (Deng et al., 2013a) . The expression levels of mature miR-31 were determined using a miRcute miRNA qPCR detection kit (Tiangen Biotech, Beijing, China). The relative mRNA and miRNA levels were normalised to the expression of GAPDH and U6, respectively, and then presented as the fold change relative to expression in miR-Neg-transduced cells.
Western blot analyses
One day after transduction by lentiviruses, the BMSCs were seeded into 6-well plates and cultured in osteoinductive medium. The cultured cells were harvested and lysed using radioimmunoprecipitation assay lysis buffer (Thermo Fisher Scientific, Waltham, MA, USA) at various time points after gene transduction. The total protein concentrations were determined using a BCA protein assay (Thermo). Equal amounts of cell lysates were separated on a 9 % SDS-PAGE gel and transferred to 0.22 μm polyvinylidene fluoride membranes (Millipore).
After blocking with 5 % non-fat milk, the membranes were probed with primary antibodies directed against Runx2, Satb2, Opn, Ocn and β-actin (Abcam, Cambridge, MA, USA) overnight at 4 °C. The membranes were then incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma). The immunoblots were visualised using an Odyssey V3.0 image scanner (LI-COR, Lincoln, NE, USA). The densitometric intensities of the individual immuno-labelled bands were quantified using Image J software, and the values were normalised relative to β-actin. The results are reported as the mean values ± SD.
Alkaline phosphatase activity and Alizarin Red S staining After BMSCs were transduced, they were seeded into 12-well plates at a density of 1.0 x 10 5 cells/well and cultured in osteo-inductive medium. Alkaline phosphatase (ALP) staining was performed according to the manufacturer's instructions (Rainbow, Shanghai, China) at day 7 (Xia et al., 2011) . Semiquantitative analysis of ALP activity was performed as previously reported (Su et al., 2012) . Briefly, after the cells were lysed, the total protein content of the samples was determined using a BCA protein assay kit. ALP activity was detected from the absorbance at 405 nm using p-nitrophenyl phosphate (p-NPP) (Sigma) as the substrate. After fixation in 95 % ethanol, the cells were incubated with 40 mM Alizarin Red S (ARS) staining solution (Sigma) for 20 min at room temperature on day 14. For ARS measurement, the stain was desorbed using 10 % cetylpyridinium chloride (Sigma) for 1 h. The solution was collected and distributed at 100 μL/well in a 96-well plate. Absorbance readings at 590 nm were obtained using a spectrophotometer (Thermo). Finally, the ALP and ARS levels were normalised to the total protein content.
Fabrication of PGS scaffolds
PGS synthesis was an improvement of an existing procedure (Wang et al., 2002) . Porous PGS scaffolds were prepared using a modified salt fusion method . Briefly, ground salt particles of 300-500 μm (300-355 μm/355-500 μm at 1/1 w/w, salt % = 95 wt %) were used as the porogens for the salt fusion. The thickness of the salt layer, which determined the thickness of the final scaffold, was easily adjusted by inserting a combination of shims of different thicknesses. The physical properties of PGS scaffolds, such as their mechanical properties and the porosity, have been systematically investigated before Crapo et al., 2008; Wu et al., 2011) . Finally, the disc-shaped (Φ 8 mm x 2 mm 3 ) porous PGS scaffolds were used for cell seeding. Twenty-four hours after a total of 2 x 10 6 freshly trypsinised BMSCs were seeded on each PGS scaffold as previous described (Gao et al., 2007) , the cell-seeded scaffolds were subjected to scanning electron microscopy (SEM) (Philips, Amsterdam, Netherlands) (Crapo et al., 2008) .
Animal experiments
All of the procedures were approved by the Animal Research Committee of the Ninth People's Hospital of the Shanghai Jiao Tong University School of Medicine. After general anaesthesia, the head of each 12-week-old male Fischer 344 rat was shaved and sterilised with 70 % ethanol. The cranium was exposed by a medial incision through the scalp and periosteum and blunt dissection to reach the calvarium. A critical-sized round bony defect was created in each rat using a dental trephine (8 mm external diameter) (Nouvag AG, Goldach, Switzerland). PGS scaffolds seeded with syngenic cells transduced with miR-Neg, miR-31 or anti-miR genes were implanted into the defects after 24 h of in vitro culture. Finally, the wound was irrigated, the fascia was sutured, and the skin was closed. Twenty-four rats were randomly assigned to one of the following four different experimental groups: (1) PGS (n = 6), (2) PGS with BMSCs/miR-Neg (n = 6), (3) PGS with BMSCs/miR-31 (n = 6), and (4) PGS with BMSCs/anti-miR (n = 6).
Micro-computed tomography analysis (micro-CT)
The animals were euthanised under general anaesthesia eight weeks after surgery, and the skulls were explanted and fixed in 4 % paraformaldehyde. The morphology of the reconstructed skulls was determined using micro-CT (μCT-80, Scanco Medical, Bassersdorf, Switzerland) with some of the same parameters described previously (Zou et al., 2011a) , including X-ray tube potential of 80 kV, tube current of 0.45 mA and 15 mm voxel resolution. A cylindrical region of interest (ROI), with a diameter of 8 mm and a height that covered the entire thickness of the calvarial bone in defects, was selected for analysis. After micro-CT scanning, the skulls were visualised using software (MicroView, GE Healthcare, Waukesha, WI, USA) that performed three-dimensional isosurface rendering. Micro-CT measurements included the ratio of new bone volume relative to the tissue volume (BV/TV) and bone mineral densities (BMDs) of the bone defect.
Histological and histomorphometric observation
The skulls were harvested and fixed in a 5 % neutral buffered formalin solution. After dehydration in increasing concentrations of alcohol (75 % to 100 %), the undecalcified specimens were embedded in polymethylmethacrylate. Three 150 μm sagittal sections of the central segment were cut using a microtome (Leica, Hamburg, Germany) Y Deng et al.
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and hand-ground and polished to a final thickness of approximately 40 μm. The sections were then stained with van Gieson's picrofuchsin to detect new bone formation. Red staining indicated new bone formation, whereas PGS appeared yellow. The surface area of the newly formed bone and PGS residue in the raised area eight weeks after the operation were calculated based on the entire area of the bone defect using the image analysis system Image-Pro Plus TM (Media Cybernetics, Silver Springs, MD, USA).
Statistical analysis
All of the in vitro studies were performed in triplicate unless otherwise specified. The data are expressed as the mean values ±SD. Statistical analysis was performed by ANOVA and SNK post hoc or Kruskal-Wallis nonparametric procedure followed by Mann-Whitney U test for multiple comparisons based on the normal distribution and equal variance assumption test, using SPSS v 17.0 statistical software package. The difference was considered statistically significant when p value is less than 0.05. The miR-Neg group was compared with the miR-31 group (designated as *p < 0.05 and **p < 0.01), and the anti-miR group was compared with the miR-Neg group (designated as #p < 0.05 and ##p < 0.01).
Results
Characterisation and gene transduction of BMSCs
Flow cytometry of isolated BMSCs showed high expression levels of the MSC markers CD90 and CD105, whereas the myeloid endothelial cell marker CD31 and haematopoietic lineage marker CD34 were rarely detected (Fig. 1) . Four days after the BMSCs were transduced by lentiviruses encoding miR-Neg, miR-31 or anti-miR genes, emission of green fluorescence was observed by fluorescence microscopy (Fig. 2a) . The efficiency of lentiviral transduction, which was calculated from the proportion of GFP-positive BMSCs detected by flow cytometry, was 88.32 ±4.09 % (Fig. 2b) . The qPCR results showed that from day 4 to 21, miR-31 was significantly overexpressed in the miR-31 group and repressed in The semiquantitative analysis of the Satb2 protein levels (the miR-Neg group was compared with the miR-31 group, *p < 0.05 and **p < 0.01; the anti-miR group were compared with the miR-Neg group, #p < 0.05 and ## p < 0.01).
(c) The mRNA levels of Satb2 were not altered by miR-31 modification.
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the anti-miR group compared with the miR-Neg group (p < 0.05) (Fig. 2c) .
Regulation of Satb2 expression by miR-31
We next evaluated whether miR-31 regulates Satb2 expression during osteogenic differentiation of BMSCs. BMSCs transduced by lentiviruses encoding miR-Neg, miR-31 or anti-miR were subjected to qPCR and western blotting 0, 1, 4, 7, 14 and 21 d after being transferred to osteo-inductive medium. Western blot analysis revealed that Satb2 protein expression increased gradually from day 4 to 21 of osteogenic induction. However, this trend was significantly counteracted by the overexpression of miR-31. In contrast, increased Satb2 expression was dramatically accelerated by knocking down miR-31 expression (Fig. 3a) . Semiquantitative analysis showed that from day 4 to 21, Satb2 protein levels were depressed and elevated approximately 2.5-fold in cells modified by miR-31 and anti-miR, respectively, relative to miRNeg-modified cells (p < 0.05) (Fig. 3b) . This suggests that miR-31 is an important negative regulator of Satb2 expression. However, the qPCR results indicated that the levels of Satb2 mRNA in the miR-31-modified BMSCs were not significantly altered by miR-31 overexpression or suppression during osteogenic induction (p > 0.05) (Fig.  3c) . It follows that miR-31 negatively modulates Satb2 expression by targeting translational but not transcriptional control.
Osteogenic differentiation of miR-31-modified BMSCs
To further assess how miR-31 mediates Satb2 protein expression during osteogenic differentiation of BMSCs transduced with miR-Neg, miR-31 or anti-miR constructs and cultured in osteo-inductive medium, a series of analyses, including qPCR, western blotting and ALP or ARS staining were performed at various time points. The mRNA levels of the osteogenic-specific markers ALP, Runx2, Opn and Ocn gradually increased in the miR-Neg group from day 4 to 21 ( Fig. 4a-d) . Notably, the mRNA expression of these markers in the anti-miR group was initially higher than that of the miR-Neg group on day 4 (p < 0.05) and dramatically increased from day 7 to 21 (p < 0.01). Interestingly, the miR-31 overexpression group showed no significant difference in the mRNA levels of osteogenic factors between the various time points (p > 0.05). The results of osteogenic protein analysis were in accordance with the corresponding qPCR findings (Fig.   Fig. 4 . Expression of osteogenic-specific markers in gene-transduced BMSCs. (a-d) The mRNA levels of key osteogenic-specific markers ALP, Runx2, Opn and Ocn in the miR-Neg group, miR-31 group and anti-miR group within 3 weeks. (e) The protein levels of Runx2, Opn and Ocn show the same pattern with qPCR findings (the miRNeg group was compared with the miR-31 group, *p < 0.05 and **p < 0.01; the anti-miR group were compared with the miR-Neg group, #p < 0.05 and ## p < 0.01).
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4e). Furthermore, semiquantitative analysis of the western blot results showed that the expression of Runx2, Opn and Ocn decreased and increased nearly 3-fold from day 4 to 21 in the miR-31 and anti-miR groups, respectively, relative to the miR-Neg group. Seven days after transduction, ALP staining was attenuated in the miR-31 group and enhanced in the antimiR group (Fig. 5a) . Furthermore, ARS staining on day 14 revealed a dramatic impairment in calcium deposition in the miR-31 group but a significant enhancement in the anti-miR group (Fig. 5c) . Semiquantitative analysis showed that on day 7, ALP activity in the miR-31 and anti-miR-31 groups was nearly 2-fold lower and higher, respectively, than in the miR-Neg group (Fig. 5b) (p < 0.05). Additionally, semiquantitative analysis of ARS staining showed the same pattern as ALP activity (Fig.  5d) (p < 0.05) . Altogether, these data suggest that miR-31 plays a pivotal role in regulating the osteo-inductive differentiation of BMSCs. 
Effect of miR-31 expression on in vivo bone regeneration Twenty-four hours after the BMSCs were seeded onto PGS scaffolds, the composites were imaged using SEM. SEM showed that the cells were attached to the surfaces of the scaffolds (Fig. 6) . We next explored whether miR-31-based modulation of osteogenic differentiation affects bone regeneration in vivo. Twenty-four hours after the scaffolds were seeded with BMSCs, four groups of composites (PGS, PGS with BMSCs/miR-Neg, PGS with BMSCs/miR-31, and PGS with BMSCs/anti-miR) were transplanted into the 8 mm CSDs in the rat calvarial model. To observe new bone formation within the bone defects, the morphology of the newly formed bone was determined by micro-CT eight weeks postoperatively. In coronal and sagittal micro-CT images, the extent of new bone formation varied significantly between the four groups (Fig. 7a) . In particular, new bone formation in the anti-miR group was greater than that in the PGS, miR-31 and miR-Neg groups. The quantity of newly formed bone within the defects was calculated using morphometric analysis. The BV/TV ratio in the miR-Neg group (22.18 ±3.39 %) was markedly higher than that in the miR-31 group (7.93 ±1.62 %) (p < 0.05) but significantly lower than that in the anti-miR group (41.82 ±6.54 %) (Fig. 7b) (p < 0.05). Additionally, the BMDs in the four groups (0.132 ±0.029 g/cm 3 in the PGS group, 0.387 ±0.048 g/ cm 3 in the miR-Neg group, 0.155 ±0.031 g/cm 3 in the miR-31 group and 0.492 ±0.062 g/cm 3 in the anti-miR group) exhibited the same pattern as the BV/TV ratios (Fig. 7c) . These findings suggest that miR-31 impairs bone repair and that anti-miR-31 greatly increases the bone regeneration potential of BMSCs.
Histological analysis of bone regeneration
The histological results obtained from van Gieson staining of non-decalcified specimens supported the micro-CT findings (Fig. 8a) . Light microscopy revealed that the percentage of new bone area after eight weeks was 15.72 ±2.55 % in the PGS group, 35.34 ±4.42 % in the miRNeg group, 13.82 ±3.42 % in the miR-31 group and 60.92 ±7.34 % in the anti-miR group (Fig. 8b) . The percentage of the residual PGS scaffold area was 46.32 ±6.85 % in the PGS group, 23.34 ±4.67 % in the miR-Neg group, 47.93 ±7.58 % in the miR-31 group and 12.82 ±2.54 % in the anti-miR group (Fig. 8c) . Altogether, these data indicate that miR-31 attenuates ossification by BMSCs and that knocking down miR-31 promotes new bone formation. 
Discussion
Tissue engineering of bone is a new therapeutic strategy for repairing bone tissue defects. Genetic therapy to enhance bone regeneration has become one of the most active areas in bone tissue engineering (Ye et al., 2011; Zou et al., 2011a) . In this study, we developed functional tissue-engineered bone by incorporating miR-31-modified BMSCs into PGS scaffolds. Anti-miR modification significantly improved the expression of osteogenicspecific marker genes and enhanced the osteogenesis of BMSCs as confirmed by qPCR, western blotting and ALP and ARS staining. The repair of 8 mm full-thickness cranial bone defects in vivo further demonstrated that anti-miR is superior to miR-Neg for bone regeneration mediated by gene delivery, likely due to the role of anti-miR in facilitating the osteogenic differentiation of exogenous BMSCs. Luciferase reporter assays have shown that direct targeting of Satb2 mRNA by miR-31 is involved in regulating tumour cell motility (Aprelikova et al., 2010) . Our results showed that during three weeks of osteogenic induction, increased Satb2 protein expression was significantly counteracted by miR-31 overexpression and accelerated by miR-31 suppression relative to miR-Negtransduced BMSCs. However, the levels of Satb2 mRNA were not significantly altered by miR-31 expression. These data confirmed that miR-31 regulates Satb2 expression at the translational but not transcriptional level and that this mechanism is in effect during cell differentiation and cancer metastasis. Additionally, our data showed that the expression of Runx2, Opn and Ocn followed the same pattern as Satb2 protein expression, which is consistent with previous studies that have demonstrated that Satb2 gene delivery accelerates the expression of osteogenic specific genes (Runx2, Opn and Ocn) and promotes bone regeneration (Yan et al., 2011; Ye et al., 2011) . Moreover, micro-CT showed that anti-miR-31 treatment significantly improved ossification in the calvarial model. In contrast, only rare new bone formation was observed in the PGS and miR-31 groups. Quantitative analysis revealed that the BV/TV ratio and the BMD of the anti-miR group were significantly higher than those of the PGS, miR-31 and miR-Neg groups. Overall, the results of our investigation of differentiated osteogenic BMSCs suggested that miR-31 plays a pivotal role in bone regeneration.
Our previous study showed that porous β-tricalcium phosphate (β-TCP) seeded with adipose-derived stem cells (ASCs) expressing miR-31 anti-sense for the repair of rat calvarial CSDs (5 mm diameter) achieved an approximately 40 % osteo-regeneration rate (Deng et al., 2013b) . In the present study, the rate of bone regeneration in an 8 mm rat calvarial CSD was approximately 60 % in the anti-miR group. Why does a higher regeneration rate occur in relatively larger bone defects? This may be due to the properties of the seeded cells and the scaffold material. A series of assays have shown that the osteogenic potential of BMSCs is greater than that of ASCs both in vitro and in vivo (Mizrahi et al., 2013) . Furthermore, our previous studies show that PGS could induce differentiation of bone marrow mononuclear cells to vascular cells and promote vascular tissue formation by adsorbing plasma proteins and platelets Lee et al., 2013) . Additionally, the process of angiogenesis is coupled with osteogenesis in bone tissue regeneration (Kanczler and Oreffo, 2008; Nguyen et al., 2012) . Therefore, the features of angiogenic 
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induction of PGS unlike with β-TCP may interpret the aforementioned phenomenon too. PGS scaffold may be a better candidate than β-TCP for tissue engineering bone. PGS is degraded by surface erosion, with simultaneous loss of linear mass and strength occurring during the resorption period. These properties are excellent for biomaterials used in bone tissue engineering. In our previous study, when implanted subcutaneously, the degradation half-life of PGS was 21 d, and complete resorption was observed by day 60 (Wang et al., 2003) . Although PGS was not completely absorbed after eight weeks in the experimental groups of the present study, the highest PGS biodegradation rate, which occurred in the anti-miR group, was associated with the best bone regeneration rate. As tissue ingrowth gradually proceeds, more giant cells participate in silk gel degradation, resulting in more space for tissue ingrowth . These results are consistent with those of another study showing that the microenvironment of bone formation and the extracellular matrix (ECM) facilitate osteoclast adhesion, mineral resorption and scaffold degradation (Mastrogiacomo et al., 2007) . Although PGS appears to be a good candidate material for tissue-engineered bone, its potential in bone repair must be assessed using a broad array of in vitro and in vivo biocompatibility assays.
BMSCs are multipotent stem cells that can differentiate into osteoblasts, chondrocytes and adipocytes (Pittenger et al., 1999) . In this study, we systematically explored the potential of miR-31-modified BMSCs grown on a PGS scaffold to repair large bone defects. Although knocking down miR-31 expression significantly enhanced the osteogenic differentiation and bone regeneration of BMSCs, the biological role of miR-31 in modulating multipotent differentiation of BMSCs requires further clarification. Moreover, the effects of PGS on ossification in tissue engineered bone must be further evaluated.
Conclusions
In this study, we showed that miR-31 negatively regulates the osteogenic differentiation of BMSCs by targeting the pivotal transcription factor Satb2. Anti-miR-31 significantly increased the osteogenic potential of BMSCs that are dependent on the prolonged overexpression of Satb2 protein. PGS is a potential candidate scaffold for bone tissue engineering. Modification of BMSCs on a PGS scaffold with anti-miR-31 is an option for repairing CSD. Our results provide preclinical data supporting the potential application of miRNA gene-modified BMSCs to repair critical-sized calvarial defects.
